Oncolytics biotech® announces voting results from the annual general meeting of shareholders

San diego and calgary, ab , may 16, 2024 /prnewswire/ -- oncolytics biotech® inc. (nasdaq: oncy) (tsx: onc), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the voting results from its annual general meeting (agm) of shareholders held on wednesday, may 15, 2024. a total of 41.34% of the issued and outstanding common shares of the corporation were represented either in person or by proxy at the meeting.
GM Ratings Summary
GM Quant Ranking